Email Updates

Search form

You are here

Browse and Order Resources

In the Report, we argue that the state of HIV prevention data collection in 2016 is poor. One part of the solution lies in the adoption of “HIV Prevention Data Dashboards”. This tracking tool could bring the same specificity and accountability to non-ART prevention services that the “treatment cascade” of diagnosis, initiation, retention and virologic suppression does for antiretrovirals for people living with HIV.

July 2016
AVAC
AVAC Report

The International AIDS Conference in Durban was a reminder of how important the meeting can be in framing global issues and priorities. This issue of Px Wire offers a look at how the Durban wrap-up catapults us into the future.

August 2016
AVAC
Px Wire

PrEP works if you take it. The figures on this graphic show the relationship between PrEP efficacy and adherence and the status of regulatory action on PrEP worldwide. It also shows other potential new formulations of ARV-based prevention being evaluated as additional options in the future.

August 2016
AVAC
Infographic

We know that an AIDS vaccine is possible and that a vaccine will be an important part of a long-term strategy to end the AIDS epidemic. The road ahead is long, but clinical trials—even those with disappointing results—and early-stage research provide critical clues to the way forward. The graphics below represent key facts about the AIDS vaccine field.

May 2016
AVAC
Infographic

The term “microbicide” refers to substances being studied that could be used in the vagina and/or rectum to reduce the risk of HIV infection via sexual exposure. There are no licensed microbicides available today. Simple, easy-to-use microbicides would help these individuals take control of their own health—while offering people everywhere an additional, needed option. The graphics below represent key facts about the microbicide field.

July 2016
AVAC
Infographic

This annual accounting of funding for biomedical HIV prevention research tracks trends and identifies gaps in investment. In 2014, the reported funding for HIV prevention R&D decreased by US$10 million from the previous year to a total of US$1.25 billion. While investments toward research in preventive vaccines, PrEP, female condoms and prevention of vertical transmission increased in 2014, investments towards microbicides, treatment as prevention and medical male circumcision decreased.

July 2015
HIV Vaccines & Microbicides Resource Tracking Working Group
AVAC
IAVI
UNAIDS
Report/Issue Brief

A handbook designed to guide the user through various communication scenarios. The handbook offers tips and strategies to navigating difficult scenarios that may occur throughout the clinical trial process. It also offers suggestions on routine scenarios such as result dissemination and training staff and spokespersons.

February 2014
FHI 360
Handbook/Manual
Training Material

A comprehensive 2012 report from civil society about the state of voluntary medical male circumcision in Africa. Includes priority recommendations and in-depth discussion of factors influencing national scale-up efforts.  

July 2012
AVAC
National Empowerment Network of People Living with HIV/AIDS in Kenya
Sonke Gender Justice Network
Uganda Network of AIDS Service Organizations
Report/Issue Brief

The Good Participatory Practice (GPP) guidelines offer trial funders, sponsors and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle of HIV Prevention Trials. This second edition of the guidelines, published in 2011, contains three sections: The Importance of Good Participatory Practice, Guiding Principles of GPP in Biomedical HIV Prevention Trials and Good Participatory Practices in Biomedical HIV Prevention Trials. The sections provide context, foundational principles and key practices.

June 2011
AVAC
UNAIDS
Handbook/Manual
Training Material

The Handbook provides comprehensive introductory material on the key scientific, policy, social, ethical and economic facets of AIDS vaccine research. While the science has changed greatly over the decade since this second edition of the Handbook was published in 2005, the themes and content in many of the essays still hold true. Edited by Patricia Kahn, the handbook contains articles by community educators and advocates, trial staff and volunteers, scientists and researchers, and policy makers and journalists.

May 2005
AVAC
Edited by Patricia Kahn
Handbook/Manual